These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 30227826)
1. Ultrastructural Investigation of Shokri A; Fakhar M; Emami S; Gill P; Akhtari J Recent Pat Antiinfect Drug Discov; 2018; 13(3):246-255. PubMed ID: 30227826 [TBL] [Abstract][Full Text] [Related]
2. Repurposing azole antifungals into antileishmanials: Novel 3-triazolylflavanones with promising in vitro antileishmanial activity against Leishmania major. Keighobadi M; Emami S; Fakhar M; Shokri A; Mirzaei H; Hosseini Teshnizi S Parasitol Int; 2019 Apr; 69():103-109. PubMed ID: 30582997 [TBL] [Abstract][Full Text] [Related]
3. An overview of azoles targeting sterol 14α-demethylase for antileishmanial therapy. Emami S; Tavangar P; Keighobadi M Eur J Med Chem; 2017 Jul; 135():241-259. PubMed ID: 28456033 [TBL] [Abstract][Full Text] [Related]
4. Antileishmanial activities and mechanisms of action of indole-based azoles. Pagniez F; Abdala-Valencia H; Marchand P; Le Borgne M; Le Baut G; Robert-Piessard S; Le Pape P J Enzyme Inhib Med Chem; 2006 Jun; 21(3):277-83. PubMed ID: 16918075 [TBL] [Abstract][Full Text] [Related]
5. In vitro antileishmanial activity of novel azoles (3-imidazolylflavanones) against promastigote and amastigote stages of Leishmania major. Shokri A; Emami S; Fakhar M; Teshnizi SH; Keighobadi M Acta Trop; 2017 Mar; 167():73-78. PubMed ID: 28017860 [TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of novel tetrahydronaphthyl azoles and related cyclohexyl azoles as antileishmanial agents. Marrapu VK; Srinivas N; Mittal M; Shakya N; Gupta S; Bhandari K Bioorg Med Chem Lett; 2011 Mar; 21(5):1407-10. PubMed ID: 21295472 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and antileishmanial activity of 5-(5-nitroaryl)-2-substituted-thio-1,3,4-thiadiazoles. Alipour E; Emami S; Yahya-Meymandi A; Nakhjiri M; Johari F; Ardestani SK; Poorrajab F; Hosseini M; Shafiee A; Foroumadi A J Enzyme Inhib Med Chem; 2011 Feb; 26(1):123-8. PubMed ID: 20578974 [TBL] [Abstract][Full Text] [Related]
8. Approved drugs successfully repurposed against Oualha R; Abdelkrim YZ; Guizani I; Harigua-Souiai E Front Cell Infect Microbiol; 2024; 14():1403589. PubMed ID: 39391884 [TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of (-)α-bisabolol as a promising agent against Leishmania amazonensis. Rottini MM; Amaral AC; Ferreira JL; Silva JR; Taniwaki NN; Souza Cda S; d'Escoffier LN; Almeida-Souza F; Hardoim Dde J; Gonçalves da Costa SC; Calabrese Kda S Exp Parasitol; 2015 Jan; 148():66-72. PubMed ID: 25448354 [TBL] [Abstract][Full Text] [Related]
10. 4-Arylamino-6-nitroquinazolines: Synthesis and their activities against neglected disease leishmaniasis. Saad SM; Ghouri N; Perveen S; Khan KM; Choudhary MI Eur J Med Chem; 2016 Jan; 108():13-20. PubMed ID: 26619389 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species. Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571 [TBL] [Abstract][Full Text] [Related]
12. Antileishmanial activity of Eugenol-rich essential oil from Ocimum gratissimum. Ueda-Nakamura T; Mendonça-Filho RR; Morgado-Díaz JA; Korehisa Maza P; Prado Dias Filho B; Aparício Garcia Cortez D; Alviano DS; Rosa Mdo S; Lopes AH; Alviano CS; Nakamura CV Parasitol Int; 2006 Jun; 55(2):99-105. PubMed ID: 16343984 [TBL] [Abstract][Full Text] [Related]
14. Tamoxifen Induces Apoptosis of Leishmania major Promastigotes in Vitro. Doroodgar M; Delavari M; Doroodgar M; Abbasi A; Taherian AA; Doroodgar A Korean J Parasitol; 2016 Feb; 54(1):9-14. PubMed ID: 26951973 [TBL] [Abstract][Full Text] [Related]
15. Promising antileishmanial activity of novel imidazole antifungal drug luliconazole against Leishmania major: In vitro and in silico studies. Shokri A; Abastabar M; Keighobadi M; Emami S; Fakhar M; Teshnizi SH; Makimura K; Rezaei-Matehkolaei A; Mirzaei H J Glob Antimicrob Resist; 2018 Sep; 14():260-265. PubMed ID: 29793051 [TBL] [Abstract][Full Text] [Related]
16. Sterol profiling of Leishmania parasites using a new HPLC-tandem mass spectrometry-based method and antifungal azoles as chemical probes reveals a key intermediate sterol that supports a branched ergosterol biosynthetic pathway. Feng M; Jin Y; Yang S; Joachim AM; Ning Y; Mori-Quiroz LM; Fromm J; Perera C; Zhang K; Werbovetz KA; Wang MZ Int J Parasitol Drugs Drug Resist; 2022 Dec; 20():27-42. PubMed ID: 35994895 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of new difluoromethyl azoles as antileishmanial agents. Ferreira SB; Costa MS; Boechat N; Bezerra RJ; Genestra MS; Canto-Cavalheiro MM; Kover WB; Ferreira VF Eur J Med Chem; 2007; 42(11-12):1388-95. PubMed ID: 17445951 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of new furanyl and thiophenyl azoles as antileishmanial agents. Marrapu VK; Mittal M; Shivahare R; Gupta S; Bhandari K Eur J Med Chem; 2011 May; 46(5):1694-700. PubMed ID: 21385661 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of ferrocenylquinoline as a potential antileishmanial agent. Yousuf M; Mukherjee D; Pal A; Dey S; Mandal S; Pal C; Adhikari S ChemMedChem; 2015 Mar; 10(3):546-54. PubMed ID: 25619822 [TBL] [Abstract][Full Text] [Related]
20. Anti-leishmanial activity of the antimicrobial peptide DRS 01 observed in Leishmania infantum (syn. Leishmania chagasi) cells. Eaton P; Bittencourt CR; Costa Silva V; Véras LM; Costa CH; Feio MJ; Leite JR Nanomedicine; 2014 Feb; 10(2):483-90. PubMed ID: 24096030 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]